| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |